Icecure Medical Stock Pattern Recognition Counterattack
| ICCM Stock | USD 0.61 -0.02 -3.17% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was eleven with a total number of output elements of fifty. The function did not return any valid pattern recognition events for the selected time horizon. The Counterattack pattern warns that Icecure Medical trend reversion is coming for existing bulling or bearing trend.
Icecure Medical Technical Analysis Modules
Most technical analysis of Icecure Medical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Icecure from various momentum indicators to cycle indicators. When you analyze Icecure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Icecure Medical
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation of tumors in the human body. The company was incorporated in 2006 and is headquartered in Caesarea, Israel. Icecure Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 55 people. A high-level view of Icecure Medical emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/B of 4.55. Icecure Medical has market cap of 42.38 M, ROE of -1.58%.
Methodology
Unless otherwise specified, financial data for Icecure Medical is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Icecure (USA Stocks:ICCM) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: This report references public filings and market reference sources and institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Certain datasets may update with delay depending on source availability. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Icecure Medical may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Icecure Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Icecure Medical's short interest history, or implied volatility extrapolated from Icecure Medical options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Investor Favorites Invested over 60 shares | |
 | Macroaxis Picks Invested few shares | |
 | Driverless Cars Invested over 200 shares | |
 | Momentum Invested over 40 shares | |
 | Baby Boomer Prospects Invested over 20 shares | |
 | Power Assets Invested over 200 shares | |
 | Impulse Invested over 200 shares | |
 | ESG Investing Invested few shares | |
More Resources for Icecure Stock Analysis
A structured review of Icecure Medical often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame Icecure Medical Stock in context:Icecure Medical has market cap of 42.38 M, operating margin of -4.51%, ROE of -1.58%. Use Risk vs Return Analysis to explore allocation context. This includes a position in Icecure Medical across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. For more information on how to buy Icecure Stock please use our How to Buy Icecure Stock guide.Analysis related to Icecure Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Earnings Share -0.25 | Revenue Per Share | Quarterly Revenue Growth 0.284 | Return On Assets | Return On Equity |
The market value of Icecure Medical is measured differently than book value, which reflects Icecure accounting equity. Icecure Medical's market capitalization is 42.38 M. With a P/B ratio of 4.55, the market values Icecure Medical well above its book equity. Enterprise value stands at 32.66 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that Icecure Medical's intrinsic value and market price are different measures derived from different inputs. For Icecure Medical, key inputs include a P/B ratio of 4.55, ROE of -1.58%, and revenue of 3.29 M. Trading price represents the transaction level agreed by market participants.